PODCAST · health
What Comes After Ozempic? Next-Gen Weight Loss Drugs
by Inception Point AI
Dr. Ben Synth explores the cutting-edge obesity drugs racing to surpass Ozempic, from Eli Lilly's triple-receptor retatrutide to Novo Nordisk's amylin strategies and the quest for a daily pill. Discover how these next-generation therapies promise weight loss exceeding 24% and could transform treatment forever.For more content like this, visit QuietPlease.aiThis content was created in partnership and with the help of Artificial Intelligence AI.
No episodes available yet.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Dr. Ben Synth explores the cutting-edge obesity drugs racing to surpass Ozempic, from Eli Lilly's triple-receptor retatrutide to Novo Nordisk's amylin strategies and the quest for a daily pill. Discover how these next-generation therapies promise weight loss exceeding 24% and could transform treatment forever.For more content like this, visit QuietPlease.aiThis content was created in partnership and with the help of Artificial Intelligence AI.
HOSTED BY
Inception Point AI
Loading similar podcasts...
URL copied to clipboard!